| 2911 |
854: Alterations, Cellular proliferation / hyperplasia |
2136: prostatic intraepithelial neoplasia |
May 11, 2023 |
May 11, 2023 |
1 AOP
|
| 2844 |
2089: Altered Bone Cell Homeostasis |
2090: Bone Remodeling |
Jan 25, 2023 |
Aug 9, 2024 |
1 AOP
|
| 3527 |
2089: Altered Bone Cell Homeostasis |
1761: Inhibition, Fin regeneration |
Apr 18, 2025 |
Apr 18, 2025 |
1 AOP
|
| 3112 |
2204: Altered brain morphology |
341: Impairment, Learning and memory |
Jan 14, 2024 |
Jan 14, 2024 |
1 AOP
|
| 3435 |
2292: Altered Cardiac Electrical Conduction |
1106: Occurrence, cardiac arrhythmia |
Nov 22, 2024 |
Nov 22, 2024 |
2 AOPs
|
| 3320 |
2245: Altered cell differentiation signaling |
2089: Altered Bone Cell Homeostasis |
Jul 24, 2024 |
Aug 23, 2024 |
2 AOPs
|
| 3110 |
2202: Altered expression of cell cycle genes |
2203: Decreased proliferation of cortical NPCs |
Jan 14, 2024 |
Jan 14, 2024 |
2 AOPs
|
| 1269 |
1214: Altered expression of hepatic CAR-dependent genes |
716: Increase, cell proliferation (hepatocytes) |
Nov 29, 2016 |
Dec 21, 2018 |
1 AOP
|
| 16 |
17: Altered expression of AHR/ARNT pathway-dependent genes |
317: Altered, Cardiovascular development/function |
Nov 29, 2016 |
Dec 3, 2016 |
None
|
| 17 |
17: Altered expression of AHR/ARNT pathway-dependent genes |
80: Up Regulation, CYP1A1 |
Nov 29, 2016 |
Dec 3, 2016 |
None
|
| 2641 |
1917: Altered expression of NRF2 pathway-dependent genes |
1815: Increase, ER stress |
Apr 8, 2022 |
Apr 8, 2022 |
1 AOP
|
| 3271 |
1917: Altered expression of NRF2 pathway-dependent genes |
1392: Increase, Oxidative Stress |
Jul 4, 2024 |
Jul 4, 2024 |
1 AOP
|
| 3194 |
2221: LXR activity, altered |
2223: Reduced number of oligodendrocytes |
Apr 12, 2024 |
Apr 12, 2024 |
1 AOP
|
| 3243 |
2005: neurotrasmission in development |
757: Hippocampal anatomy, Altered |
Jun 3, 2024 |
Jul 31, 2024 |
1 AOP
|
| 2773 |
2066: Altered Signaling |
2067: Altered, Nitric Oxide Levels |
Sep 28, 2022 |
Mar 21, 2023 |
None
|
| 2775 |
2066: Altered Signaling |
2068: Increase, Endothelial Dysfunction |
Sep 28, 2022 |
Mar 21, 2023 |
None
|
| 2840 |
2066: Altered Signaling |
2098: Abnormal Neural Remodeling |
Jan 25, 2023 |
Mar 21, 2023 |
None
|
| 2843 |
2066: Altered Signaling |
2089: Altered Bone Cell Homeostasis |
Jan 25, 2023 |
Mar 22, 2023 |
None
|
| 3400 |
2066: Altered Signaling |
1924: Increased,Cardiac fibrosis |
Nov 20, 2024 |
Nov 20, 2024 |
1 AOP
|
| 3317 |
2244: Altered Stress Response Signaling |
2067: Altered, Nitric Oxide Levels |
Jul 24, 2024 |
Aug 26, 2024 |
1 AOP
|
| 3318 |
2244: Altered Stress Response Signaling |
2068: Increase, Endothelial Dysfunction |
Jul 24, 2024 |
Aug 26, 2024 |
1 AOP
|
| 3321 |
2244: Altered Stress Response Signaling |
2098: Abnormal Neural Remodeling |
Jul 24, 2024 |
Jul 25, 2024 |
1 AOP
|
| 702 |
698: Altered, Action Potential |
699: Increased, cardiac arrthymia |
Nov 29, 2016 |
Dec 3, 2016 |
1 AOP
|
| 3407 |
698: Altered, Action Potential |
1962: Prolongation of QT interval |
Nov 20, 2024 |
Nov 20, 2024 |
1 AOP
|
| 3415 |
698: Altered, Action Potential |
1532: Decrease, Cardiac contractility |
Nov 21, 2024 |
Nov 21, 2024 |
1 AOP
|